日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

HIV-1疫苗诱导人体黏膜抗体的荟萃分析

Seaton, Kelly E; Deal, Aaron; Han, Xue; Li, Shuying S; Clayton, Ashley; Heptinstall, Jack; Duerr, Ann; Allen, Mary A; Shen, Xiaoying; Sawant, Sheetal; Yates, Nicole L; Spearman, Paul; Churchyard, Gavin; Goepfert, Paul A; Maenza, Janine; Gray, Glenda; Pantaleo, Giuseppe; Polakowski, Laura; Robinson, Harriet L; Grant, Shannon; Randhawa, April K; Huang, Ying; Morgan, Cecilia; Grunenberg, Nicole; Karuna, Shelly; Gilbert, Peter B; McElrath, M Juliana; Huang, Yunda; Tomaras, Georgia D

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

疫苗类型对HIV-1疫苗诱导的抗体持久性和B细胞基因特征的影响

Palli, Rohith; Seaton, Kelly E; Piepenbrink, Michael S; Hural, John; Goepfert, Paul A; Laher, Fatima; Buchbinder, Susan P; Churchyard, Gavin; Gray, Glenda E; Robinson, Harriet L; Huang, Yunda; Janes, Holly; Kobie, James J; Keefer, Michael C; Tomaras, Georgia D; Thakar, Juilee

HIV/AIDS Vaccines: 2018

艾滋病毒/艾滋病疫苗:2018 年

Robinson, Harriet L

Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine

埃博拉病毒——基于安卡拉的新型病毒样颗粒表达改良痘苗疫苗的前景

Robinson, Harriet L; Marzi, Andrea

One Group's Historical Reflections on DNA Vaccine Development

一个小组对DNA疫苗研发的历史反思

Fynan, Ellen F; Lu, Shan; Robinson, Harriet L

A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge

单剂表达埃博拉病毒样颗粒的改良型安卡拉痘苗病毒可保护非人灵长类动物免受致命的埃博拉病毒攻击

Domi, Arban; Feldmann, Friederike; Basu, Rahul; McCurley, Nathanael; Shifflett, Kyle; Emanuel, Jackson; Hellerstein, Michael S; Guirakhoo, Farshad; Orlandi, Chiara; Flinko, Robin; Lewis, George K; Hanley, Patrick W; Feldmann, Heinz; Robinson, Harriet L; Marzi, Andrea

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site

HIV传播/创始人疫苗可诱导产生针对CD4结合位点的自体二级中和抗体

McCurley, Nathanael P; Domi, Arban; Basu, Rahul; Saunders, Kevin O; LaBranche, Celia C; Montefiori, David C; Haynes, Barton F; Robinson, Harriet L

High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques

高剂量GM-CSF抑制直肠分泌物中的抗体反应,并降低TRIM5α限制性猕猴对改良型痘苗病毒安卡拉株/猴免疫缺陷病毒疫苗的保护作用

Kannanganat, Sunil; Wyatt, Linda S; Gangadhara, Sailaja; Chamcha, Venkatesarlu; Chea, Lynette S; Kozlowski, Pamela A; LaBranche, Celia C; Chennareddi, Lakshmi; Lawson, Benton; Reddy, Pradeep B J; Styles, Tiffany M; Vanderford, Thomas H; Montefiori, David C; Moss, Bernard; Robinson, Harriet L; Amara, Rama Rao

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.

对接受抗逆转录病毒治疗且病毒得到抑制的 HIV-1 感染者进行 DNA/MVA 疫苗接种,随后中断治疗:在无法控制病毒再次出现的情况下诱导免疫反应

Thompson Melanie, Heath Sonya L, Sweeton Bentley, Williams Kathy, Cunningham Pamela, Keele Brandon F, Sen Sharon, Palmer Brent E, Chomont Nicolas, Xu Yongxian, Basu Rahul, Hellerstein Michael S, Kwa Suefen, Robinson Harriet L

CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge

CD40L佐剂DNA/改良痘苗病毒安卡拉株SIV239疫苗可增强SIV特异性体液免疫和细胞免疫,并提高对异源性SIV660黏膜攻击的保护作用

Kwa, Suefen; Lai, Lilin; Gangadhara, Sailaja; Siddiqui, Mariam; Pillai, Vinod B; Labranche, Celia; Yu, Tianwei; Moss, Bernard; Montefiori, David C; Robinson, Harriet L; Kozlowski, Pamela A; Amara, Rama Rao